| Elizabeth Arena Rook, DO, MPH | |
|
1401 25th St S, Great Falls, MT 59405-5183 | |
| (406) 731-8888 | |
| (406) 731-8318 |
| Full Name | Elizabeth Arena Rook |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 18 Years |
| Location | 1401 25th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881878759 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | DR.0061640 (Colorado) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 113913 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Marys Medical Center | Grand junction, CO | Hospital |
| Delta County Memorial Hospital | Delta, CO | Hospital |
| Montrose Memorial Hospital | Montrose, CO | Hospital |
| Valley View Hospital Association | Glenwood springs, CO | Hospital |
| Community Hospital | Grand junction, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scl Health Medical Group - Grand Junction Llc | 3779707856 | 207 |
News Archive
The Federal Drug Administration (FDA) has recently decided to strengthen warning labels on the oral contraceptive YAZ and its sister drug Yasmin regarding increased risks of blood clots from using the medications.
The high rates of elderly UK women with breast cancer who do not undergo surgical treatment are not entirely explained by the presence of comorbidities, report UK researchers.
The addition of the drug gemcitabine with chemoradiation for the treatment of patients who had surgery for pancreatic cancer was associated with a survival benefit, although this improvement was not statistically significant, according to a study in the March 5 issue of JAMA.
Scientists have revealed never-before-seen details of how our brain sends rapid-fire messages between its cells. They mapped the 3-D atomic structure of a two-part protein complex that controls the release of signaling chemicals, called neurotransmitters, from brain cells. Understanding how cells release those signals in less than one-thousandth of a second could help launch a new wave of research on drugs for treating brain disorders.
› Verified 5 days ago
| Entity Name | Lower Valley Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Public Health/welfare Agency |
| Entity Identifiers | NPI Number: 1609190206 PECOS PAC ID: 4284526021 Enrollment ID: O20040326000937 |
News Archive
The Federal Drug Administration (FDA) has recently decided to strengthen warning labels on the oral contraceptive YAZ and its sister drug Yasmin regarding increased risks of blood clots from using the medications.
The high rates of elderly UK women with breast cancer who do not undergo surgical treatment are not entirely explained by the presence of comorbidities, report UK researchers.
The addition of the drug gemcitabine with chemoradiation for the treatment of patients who had surgery for pancreatic cancer was associated with a survival benefit, although this improvement was not statistically significant, according to a study in the March 5 issue of JAMA.
Scientists have revealed never-before-seen details of how our brain sends rapid-fire messages between its cells. They mapped the 3-D atomic structure of a two-part protein complex that controls the release of signaling chemicals, called neurotransmitters, from brain cells. Understanding how cells release those signals in less than one-thousandth of a second could help launch a new wave of research on drugs for treating brain disorders.
› Verified 5 days ago
| Entity Name | Scl Health Medical Group - Grand Junction Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356765556 PECOS PAC ID: 3779707856 Enrollment ID: O20140611000363 |
News Archive
The Federal Drug Administration (FDA) has recently decided to strengthen warning labels on the oral contraceptive YAZ and its sister drug Yasmin regarding increased risks of blood clots from using the medications.
The high rates of elderly UK women with breast cancer who do not undergo surgical treatment are not entirely explained by the presence of comorbidities, report UK researchers.
The addition of the drug gemcitabine with chemoradiation for the treatment of patients who had surgery for pancreatic cancer was associated with a survival benefit, although this improvement was not statistically significant, according to a study in the March 5 issue of JAMA.
Scientists have revealed never-before-seen details of how our brain sends rapid-fire messages between its cells. They mapped the 3-D atomic structure of a two-part protein complex that controls the release of signaling chemicals, called neurotransmitters, from brain cells. Understanding how cells release those signals in less than one-thousandth of a second could help launch a new wave of research on drugs for treating brain disorders.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Arena Rook, DO, MPH 1401 25th St S, Great Falls, MT 59405-5183 Ph: (406) 731-8888 | Elizabeth Arena Rook, DO, MPH 1401 25th St S, Great Falls, MT 59405-5183 Ph: (406) 731-8888 |
News Archive
The Federal Drug Administration (FDA) has recently decided to strengthen warning labels on the oral contraceptive YAZ and its sister drug Yasmin regarding increased risks of blood clots from using the medications.
The high rates of elderly UK women with breast cancer who do not undergo surgical treatment are not entirely explained by the presence of comorbidities, report UK researchers.
The addition of the drug gemcitabine with chemoradiation for the treatment of patients who had surgery for pancreatic cancer was associated with a survival benefit, although this improvement was not statistically significant, according to a study in the March 5 issue of JAMA.
Scientists have revealed never-before-seen details of how our brain sends rapid-fire messages between its cells. They mapped the 3-D atomic structure of a two-part protein complex that controls the release of signaling chemicals, called neurotransmitters, from brain cells. Understanding how cells release those signals in less than one-thousandth of a second could help launch a new wave of research on drugs for treating brain disorders.
› Verified 5 days ago
Edmund J Brennan, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1101 26th St S, Great Falls, MT 59405 Phone: 406-731-8888 | |
David E Anderson, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1917 4th St S, Great Falls, MT 59405 Phone: 406-453-7570 Fax: 406-771-3021 | |
Steven P Akre, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S, Great Falls, MT 59405 Phone: 406-454-2171 Fax: 406-771-3021 | |
Mr. Donald Hall Berdeaux, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1117 29th St S, Great Falls, MT 59405 Phone: 406-731-8200 Fax: 406-731-8178 | |
Paul Fredrick Schmook, RPSGT Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1917 4th St S, Great Falls, MT 59405 Phone: 406-453-7570 | |
Dr. Kirsten Elizabeth Krauss, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1417 9th St S Ste 200, Great Falls, MT 59405 Phone: 406-454-8070 Fax: 406-454-8072 | |
Bradford A Bergman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1401 25th St S, Great Falls, MT 59405 Phone: 406-731-8888 Fax: 406-731-8876 |